Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM
Condition(s):Diabetes MellitusLast Updated:May 12, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes MellitusLast Updated:May 12, 2010Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:September 25, 2013Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:March 13, 2019Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:August 5, 2020Completed
Condition(s):Coronary Heart Disease; Acute Coronary Syndrome; Impaired Glucose Tolerance; Type 2 Diabetes Mellitus (T2DM)Last Updated:July 25, 2017Completed
Condition(s):Diabetes MellitusLast Updated:June 15, 2016Withdrawn
Condition(s):Type 2 Diabetes MellitusLast Updated:November 11, 2011Completed
Condition(s):Type 2 Diabetes Mellitus; Obesity; Cognitive ImpairmentLast Updated:May 23, 2019Unknown status
Condition(s):Diabetes MellitusLast Updated:May 4, 2012Completed
Condition(s):Type 2 DiabetesLast Updated:July 6, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.